766 related articles for article (PubMed ID: 28151458)
1. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial.
Badar A; Kaatabi H; Bamosa A; Al-Elq A; Abou-Hozaifa B; Lebda F; Alkhadra A; Al-Almaie S
Ann Saudi Med; 2017; 37(1):56-63. PubMed ID: 28151458
[TBL] [Abstract][Full Text] [Related]
2. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial.
Panahi Y; Khalili N; Sahebi E; Namazi S; Reiner Ž; Majeed M; Sahebkar A
Complement Ther Med; 2017 Aug; 33():1-5. PubMed ID: 28735818
[TBL] [Abstract][Full Text] [Related]
3. Nigella sativa improves glucose homeostasis and serum lipids in type 2 diabetes: A systematic review and meta-analysis.
Daryabeygi-Khotbehsara R; Golzarand M; Ghaffari MP; Djafarian K
Complement Ther Med; 2017 Dec; 35():6-13. PubMed ID: 29154069
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial.
Derosa G; Cicero AF; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Fassi R; Fogari R
Clin Ther; 2007 Apr; 29(4):602-10. PubMed ID: 17617283
[TBL] [Abstract][Full Text] [Related]
5. Effects of pomegranate juice consumption on blood pressure and lipid profile in patients with type 2 diabetes: A single-blind randomized clinical trial.
Sohrab G; Roshan H; Ebrahimof S; Nikpayam O; Sotoudeh G; Siasi F
Clin Nutr ESPEN; 2019 Feb; 29():30-35. PubMed ID: 30661697
[TBL] [Abstract][Full Text] [Related]
6. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial.
Kaatabi H; Bamosa AO; Badar A; Al-Elq A; Abou-Hozaifa B; Lebda F; Al-Khadra A; Al-Almaie S
PLoS One; 2015; 10(2):e0113486. PubMed ID: 25706772
[TBL] [Abstract][Full Text] [Related]
7. Correlation Analysis and Intervention Study on Disturbance of Lipid Metabolism and Diabetic Peripheral Neuropathy.
Wang W; Li X; Ren Y
Comput Math Methods Med; 2022; 2022():2579692. PubMed ID: 35242203
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled trial of a proprietary lipid-lowering nutraceutical supplement in the management of dyslipidemia.
Houston M; Rountree R; Lamb J; Phipps S; Meng S; Zhang B
J Biol Regul Homeost Agents; 2016; 30(4):1115-1123. PubMed ID: 28078862
[TBL] [Abstract][Full Text] [Related]
10. Nigella sativa (black seed) effects on plasma lipid concentrations in humans: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sahebkar A; Beccuti G; Simental-Mendía LE; Nobili V; Bo S
Pharmacol Res; 2016 Apr; 106():37-50. PubMed ID: 26875640
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
12. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.
Geohas J; Daly A; Juturu V; Finch M; Komorowski JR
Am J Med Sci; 2007 Mar; 333(3):145-53. PubMed ID: 17496732
[TBL] [Abstract][Full Text] [Related]
13. Anti-hyperglycemic and anti-hyperlipidemic effects of Vaccinium myrtillus fruit in experimentally induced diabetes (antidiabetic effect of Vaccinium myrtillus fruit).
Asgary S; RafieianKopaei M; Sahebkar A; Shamsi F; Goli-malekabadi N
J Sci Food Agric; 2016 Feb; 96(3):764-8. PubMed ID: 25704796
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
[TBL] [Abstract][Full Text] [Related]
15.
Rao AS; Hegde S; Pacioretty LM; DeBenedetto J; Babish JG
J Med Food; 2020 Sep; 23(9):905-919. PubMed ID: 32758056
[TBL] [Abstract][Full Text] [Related]
16. Genetic influence on blood pressure and lipid parameters in a sample of Polish twins.
Jedrusik P; Januszewicz A; Busjahn A; Zawadzki B; Wocial B; Ignatowska-Switalska H; Berent H; Kuczyńska K; Oniszczenko W; Strelau J; Luft FC; Januszewicz W
Blood Press; 2003; 12(1):7-11. PubMed ID: 12699129
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension.
Dehkordi FR; Kamkhah AF
Fundam Clin Pharmacol; 2008 Aug; 22(4):447-52. PubMed ID: 18705755
[TBL] [Abstract][Full Text] [Related]
18. Effects of Nigella sativa supplementation on lipid profiles in adults: An updated systematic review and meta-analysis of randomized controlled trials.
Rounagh M; Musazadeh V; Hosseininejad-Mohebati A; Falahatzadeh M; Kavyani Z; Rostami RB; Vajdi M
Clin Nutr ESPEN; 2024 Jun; 61():168-180. PubMed ID: 38777430
[TBL] [Abstract][Full Text] [Related]
19. Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.
Cai Y; Xing G; Shen T; Zhang S; Rao J; Shi R
Lipids Health Dis; 2017 Dec; 16(1):251. PubMed ID: 29273027
[TBL] [Abstract][Full Text] [Related]
20. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
